It is generally accepted that the chronic use of aspirin and some other non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of colorectal cancer (CRC). A new study shows that this beneficial effect may not apply to everyone.
personalized medicine
In today s Why didn t I think of that? feature, a simple, but elegant solution that could partially eliminate the guessing game: Which chemotherapy drugs are better to treat a given cancer?
While some chemotherapy regimens are well-established to treat a certain type of cancer, in some ways, cancer chemotherapy is still a guessing game.
Hats off to Paul Howard at the Manhattan Institute for a fascinating and very timely commentary entitled Sure, We'll (Eventually) Beat Cancer. But Can We Afford To?
Howard s piece is about the disconnect between emerging scientific advances to fight cancer and our ability as a society to pay for them.
Now, another, recently-discovered mutant gene seems to be associated with a 38 percent increased risk of having a heart attack, in men at least. And the gene was found in about one-eighth of those men tested, making this quite an interesting and potentially highly important risk factor.